Actemra 160mg, a treatment known scientifically as tocilizumab, functions as a potent pharmaceutical agent primarily utilized for the treatment of rheumatoid arthritis. This remarkable substance operates by interfering with the activity of interleukin-6 (IL-6), a regulatory protein crucial in the inflammatory process. Additionally, Actemra exhibit